Mitazalimab
- Generic Name
- Mitazalimab
- Drug Type
- Biotech
- CAS Number
- 2055640-86-1
- Unique Ingredient Identifier
- Q9J81E7VFM
Overview
Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).
Background
Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath